• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Current Transplantation Reports

    Current Transplantation Reports

    JournalISSN 2196-3029eISSN 2196-3029中科院 医学 4区

    年发文量

    研究主题

    论文(525)

    排序
    1Pancreas Transplantation: Surgical Techniques and Perioperative Management
    Jonathan A. Fridell,Andrew J. Lutz,John A. Powelson,Robert J. Stratta

    Pancreas transplantation is currently the only therapy that can reliably establish long-term glucose control independent of exogenous insulin administration. Since the introduction of pancreas transplantation nearly sixty years ago, outcomes have steadily improved in the ensuing decades secondary to a marked decrease in early technical allograft failures. This positive trend in outcomes is the consequence of advances in donor selection and management, organ retrieval and preservation, recipient selection and overall medical care, surgical techniques and perioperative management, diagnostic and interventional methodology, immunosuppression medications and strategies, and anti-infective prophylaxis. In this review, surgical techniques for pancreas allograft implantation will be described, with a focus on the prevention, identification, and management of technical complications. Early post-operative management during the index hospitalization will also be discussed with an emphasis on anticipating and managing the sequelae of long-term diabetes that may complicate the immediate post-operative course.

    2026
    引用
    AI阅读
    加入学术空间
    2Immunosuppression Strategies Including the Use of Belatacept, Mtor Inhibitors and Steroid-Sparing Protocols
    Sambhavi Krishnamoorthy, Yvonne El Kassis,Beatrice P. Concepcion,Yousuf Kyeso

    Maintenance immunosuppression for pancreas transplantation has been largely derived from kidney transplant practice. The combination of a calcineurin inhibitor (CNI), mycophenolate and corticosteroids remains the backbone of immunosuppression in pancreas transplantation. Although this regimen achieves very low rejection rates and excellent short-term survival, progressive CNI-induced nephrotoxicity, β-cell injury, and cardiovascular and metabolic adverse effects carry significant long-term consequences among pancreas transplant recipients. This review examines the utility of CNI withdrawal or minimization by utilizing belatacept and/or mammalian target of rapamycin (mTOR) inhibitors, and the utility of steroid-sparing regimens in pancreas transplantation. Belatacept is associated with an increased risk of acute rejection when used in the setting of CNI withdrawal but can be effective when added to a low-dose CNI regimen. Late conversion while maintaining a low-dose CNI is associated with better allograft survival and lower rejection rates. Steroid withdrawal can be successful in the low immunologic risk population when paired with effective adjunct maintenance immunosuppression. mTOR inhibitors are associated with higher drug intolerance but may confer benefits depending on the timing, immunologic risk and infection status. Outcomes are determined by the immunosuppression that remains rather than the agent that was withdrawn. Pancreas allograft survival is impacted by the occurrence and severity of rejection regardless of the combination of immunosuppression that is utilized. An individualized approach guided by transplant type, immunologic risk, timing of intervention, and cardiometabolic and infectious risks is of utmost importance in managing immunosuppression among pancreas transplant recipients.

    2026
    引用
    AI阅读
    加入学术空间
    3Diverse Regulatory Cell Populations in Antibody Mediated Rejection
    Eugenia Karulina,Michael Nicosia

    Antibody-mediated rejection (ABMR) is a leading cause of late graft loss, and current therapies act almost exclusively on the effector arm of the alloimmune response. This review examines three classes of regulatory cell from innate and adaptive lineages and the stages of the ABMR response at which each acts, in order to assess their potential as therapeutic targets. CD4⁺ Tregs constrain alloimmune priming through CTLA4 dependent costimulatory blockade, cytokine-mediated suppression, and competition for IL-2. CXCR5⁺CD8⁺ antibody-suppressor cells directly eliminate donor-reactive IgG⁺ B cells in murine models. T follicular regulatory (Tfr) cells restrain germinal center reactions and alloantibody generation, and their loss produces enhanced, more pathogenic donor-specific antibody (DSA). Notably, Tfr regulation is initiated early in T-B interactions, Tfr expansion physiologically lags that of Tfh cells, and Tfr numbers are reduced in chronic ABMR. Regulatory B cells and myeloid-derived suppressor cells remain comparatively unexplored in ABMR, and the latter carry a risk of profibrotic differentiation under chronic inflammatory conditions. Regulatory cell populations act predominantly during the early phases of the alloimmune response. Their therapeutic utility in ABMR is therefore likely to be constrained by timing, and to lie in the prevention of de novo DSA rather than the reversal of established rejection.

    2026
    引用
    AI阅读
    加入学术空间
    4From Spectra to Clinical Insight: Raman Spectroscopy in Kidney Transplant Monitoring and Donor Assessment
    Emma Peveri,Amish Asthana,Lori N. Byers, Ryan Senger, Sayed Issa,John Robertson, Deanna M. Dehoff,Giuseppe Orlando

    Raman spectroscopy and surface-enhanced Raman scattering (SERS) are analytical techniques for non-invasive assessment of kidney transplant health. By producing molecular fingerprints through inelastic light scattering, they’re able to detect biochemical changes associated with graft injury, immune activation, and other relevant pathophysiological changes. This review synthesizes current evidence of Raman-based techniques across three key domains in kidney transplantation: transplant monitoring, donor organ assessment, and evaluation of alloreactive immune activation. Recent studies demonstrate that SERS can be applied to biofluids and can accurately distinguish between transplant states. Additionally, Raman-based analyses of donor-derived samples show potential for predicting transplant outcomes and identifying viable organs despite high-risk features. It has also been shown to differentiate between activated and non-activated T lymphocytes. Raman spectroscopy and SERS represent powerful, non-invasive approaches that have the potential to reduce the reliance on invasive biopsy.

    2026
    引用
    AI阅读
    加入学术空间
    5Pancreas Transplant Training in the United States: Trends and Implications
    Santosh Nagaraju, Matthew K. Harris, Ty B. Dunn

    Over the past two decades, pancreas transplantation in the United States has experienced a marked and persistent decrease in activity at the national and programmatic levels. Recently, significant increases in donation after circulatory death cases and the use of perfusion technologies have culminated in a major threat to training the future pancreas transplant workforce. Although pancreas transplantation remains the only established surgical therapy providing long-term insulin independence for people managing insulin dependent diabetes, declining procedure numbers have undermined surgical and medical training opportunities in this technically complex field. The effect of less training is evident in both the recovery and transplant settings. This paper examines national trends in pancreas transplant activity, the workforce in place, and fellowship training exposure. Through this lens we explore the systemic drivers and implications for the future pancreas transplant workforce and future patient access to pancreas transplantation.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 525 篇论文

    高被引作者

    作者引用发文
    Shaf Keshavjee14992
    Jonathan Yeung13771
    Melanie Brunel3521
    Antoine Durrbach3521
    Florence Herr3521
    Krista Lentine26218
    Philipp Dutkowski1813
    Andrea Schlegel1792
    Christopher J. E. Watson1422
    Sarah A. Hosgood1231

    高产作者

    作者引用发文
    Krista Lentine26218
    Dorry L. Segev658
    Yasar Caliskan567
    Giuseppe Orlando1006
    Forbes Rachel C106
    Asthana Amish245
    Ty B. Dunn705
    Jonathan A Fridell155
    Mara A. McAdams Demarco645
    Bob Stratta1005

    相关期刊

    Clinical Transplantation
    Transplantation Reviews
    Transplantation
    Annals of transplantation
    Current opinion in organ transplantation
    World journal of transplantation
    International journal of organ transplantation medicine
    Transplantation direct
    OBM transplantation
    Transplant International